Efficacy and safety profile of phosphodiesterase 4 inhibitor in the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Systemic therapy is an important treatment for psoriasis. Phosphodiesterase 4 (PDE4) inhibitors are new candidates for psoriasis therapy. OBJECTIVES: To evaluate the efficacy and safety of PDE4 inhibitors in psoriasis. METHOD: Randomized clinical trials with PDE4 inhibitors vs placebos i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Qin, Chen, Jing-si, Yang, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589065/
https://www.ncbi.nlm.nih.gov/pubmed/36300119
http://dx.doi.org/10.3389/fimmu.2022.1021537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589065/
https://www.ncbi.nlm.nih.gov/pubmed/36300119
http://dx.doi.org/10.3389/fimmu.2022.1021537

Ejemplares similares